年別の研究成果
年別の研究成果
検索結果
-
2022
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B) (International Journal of Clinical Oncology, (2022), 27, 1, (112-120), 10.1007/s10147-021-02043-2)
Tsubata, Y., Watanabe, K., Saito, R., Nakamura, A., Yoshioka, H., Morita, M., Honda, R., Kanaji, N., Oizumi, S., Jingu, D., Nakagawa, T., Nakazawa, K., Mouri, A., Takeuchi, S., Furuya, N., Akazawa, Y., Miura, K., Ichihara, E., Maemondo, M. & Morita, S. & 2 others, , 4月 2022, In: International Journal of Clinical Oncology. 27, 4, p. 823-824 2 p.研究成果 › 査読
Open Access -
2021
Erratum: Impact of previous thoracic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer (Japanese Journal of Clinical Oncology (2021) 51:2 (279-286) DOI: 10.1093/jjco/hyaa180)
Hosokawa, S., Ichihara, E., Bessho, A., Harada, D., Inoue, K., Shibayama, T., Kishino, D., Harita, S., Ochi, N., Oda, N., Hara, N., Hotta, K., Maeda, Y. & Kiura, K., 8月 1 2021, In: Japanese journal of clinical oncology. 51, 8, p. 1348 1 p.研究成果 › 査読
Open Access -
2015
Shades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung Cancer
Ichihara, E. & Lovly, C. M., 7月 1 2015, In: Cancer discovery. 5, 7, p. 694-696 3 p.研究成果 › 査読
Open Access16 被引用数 (Scopus)